Annual Drug Patent Expirations for BINOSTO
Binosto is a drug marketed by Ascend Theraps Us and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has ten patent family members in seven countries.
The generic ingredient in BINOSTO is alendronate sodium. One supplier is listed for this compound. Additional details are available on the alendronate sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
